Tarsus Pharmaceuticals, Inc.TARSNASDAQ
Loading
Expenses from normal business operations (SG&A, R&D, etc.)
| Period | Value | YoY Change |
|---|---|---|
| TTM | $475.36M | +63.5% |
| 2024 | $290.70M | +82.8% |
| 2023 | $159.01M | +81.6% |
| 2022 | $87.57M | +30.5% |
| 2021 | $67.11M | +151.0% |
| 2020 | $26.74M | +533.0% |
| 2019 | $4.22M | +213.1% |
| 2018 | $1.35M | - |